Eosinophilic granulomatosis with polyangiitis following flu guard influenza vaccination: A case report.

autoimmunity eosinophilic granulomatosis with polyangiitis (EGPA) influenza vaccine vaccination vasculitis

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 11 09 2023
revised: 17 10 2023
accepted: 30 10 2023
medline: 29 11 2023
pubmed: 29 11 2023
entrez: 29 11 2023
Statut: epublish

Résumé

This case highlights a potential association between influenza vaccination and the development of eosinophilic granulomatosis with polyangiitis (EGPA), prompting the need for increased vigilance regarding vaccine-related autoimmune reactions. While causality remains unclear, clinicians should consider this possibility in patients presenting with EGPA-like symptoms shortly after vaccination. Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic vasculitis characterized by tissue infiltration by eosinophils and hyper eosinophilia. We present a case of EGPA in a middle-aged man following influenza vaccination. The patient developed respiratory symptoms, skin lesions, joint pain, and neurological deficits. Diagnostic tests revealed eosinophilia, positive anti-neutrophil cytoplasmic antibodies, and elevated acute phase reactants. This report highlights a potential association between influenza vaccination and EGPA.

Identifiants

pubmed: 38028088
doi: 10.1002/ccr3.8217
pii: CCR38217
pmc: PMC10675098
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8217

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors declared that they have no conflict of interest.

Références

Vaccines (Basel). 2021 Jul 22;9(8):
pubmed: 34451940
Nat Commun. 2019 Nov 12;10(1):5120
pubmed: 31719529
Cureus. 2022 Jan 12;14(1):e21176
pubmed: 35165624
Semin Respir Crit Care Med. 2018 Aug;39(4):471-481
pubmed: 30404114
Ann Rheum Dis. 2014 May;73(5):890-6
pubmed: 23592712
Acta Neurol Taiwan. 2014 Sep;23(3):95-101
pubmed: 26077181
Vaccines (Basel). 2022 May 03;10(5):
pubmed: 35632472
Nat Rev Rheumatol. 2022 Oct;18(10):559-574
pubmed: 36109667
Ann Rheum Dis. 2022 Mar;81(3):309-314
pubmed: 35110334
Front Med (Lausanne). 2021 Feb 24;8:627776
pubmed: 33718405
Curr Rheumatol Rev. 2017;13(3):188-196
pubmed: 28521688
Front Immunol. 2021 Mar 26;12:624848
pubmed: 33841406
Int Immunopharmacol. 2022 Sep;110:109061
pubmed: 35978510

Auteurs

Mehdi Jafarpour (M)

Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.

Sara Daneshvar (S)

Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.

Amir Taher Eftekharsadat (AT)

Department of Pathology Imam Reza Hospital Tabriz University of Medical Sciences Tabriz Iran.

Alireza Khabbazi (A)

Connective Tissue Diseases Research Center Tabriz University of Medical Sciences Tabriz Iran.

Omid Pourbagherian (O)

Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran.

Classifications MeSH